EDGAR Filing Documents for 0001615774-15-002489

Form 10-12G - Registration of securities [Section 12(g)]:

SEC Accession No. 0001615774-15-002489

Filing Date

2015-09-08

Accepted

2015-09-08 09:12:55

Documents

Document Format Files

Seq	Description	Document	Type	Size
1	FORM 10-12G	s101780_10-12g.htm	10-12G	675388
2	EXHIBIT 3.1	s101780_ex3-1.htm	EX-3.1	62271
3	EXHIBIT 3.2	s101780_ex3-2.htm	EX-3.2	6868
4	EXHIBIT 3.3	s101780_ex3-3.htm	EX-3.3	152077
5	EXHIBIT 4.1	s101780_ex4-1.htm	EX-4.1	2533
6	EXHIBIT 4.2	s101780_ex4-2.htm	EX-4.2	55367
7	EXHIBIT 10.2	s101780_ex10-2.htm	EX-10.2	46684
8	EXHIBIT 10.3	s101780_ex10-3.htm	EX-10.3	45765
9	EXHIBIT 10.4	s101780_ex10-4.htm	EX-10.4	57076
10	EXHIBIT 10.8	s101780_ex10-8.htm	EX-10.8	181801
11	GRAPHIC	img001_v1.jpg	GRAPHIC	94637
12	GRAPHIC	img002_v1.jpg	GRAPHIC	54474
	Complete submission text file	0001615774-15-002489.txt		1492371

Mailing Address 3 COLUMBUS CIRCLE 15TH FLOOR NEW YORK NY 10019

Business Address 3 COLUMBUS CIRCLE 15TH FLOOR NEW YORK NY 10019 212-554-4366

Checkpoint Therapeutics, Inc. (Filer) CIK: 0001651407 (see all company filings)